These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7240744)

  • 41. Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate.
    Schmidt A; Ortaldo JR; Herberman RB
    J Immunol; 1984 Jan; 132(1):146-50. PubMed ID: 6690602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lectin-dependent cell-mediated cytotoxicity and blastogenesis by large granular-enriched and depleted lymphocytes.
    Perl A; Gonzalez-Cabello R; Laskay T; Benczur M; Láng I; Onódy K; Nékám K; Gergely P; Fehér J
    Clin Exp Immunol; 1986 Jan; 63(1):171-8. PubMed ID: 3955881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
    Goto T; Herberman RB; Maluish A; Strong DM
    J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
    Flexman JP; Shellam GR
    Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer-type lysis of thymocytes from young mice by normal spleen cells in vitro.
    Granberg SC; Patel MR; Linna TJ
    Nat Immun Cell Growth Regul; 1985; 4(4):184-92. PubMed ID: 3877866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.
    Stavrou D; Bilzer T; Anzil AP; Hultén M; Kaldrymidou E
    Anticancer Res; 1981; 1(3):125-34. PubMed ID: 7342850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of in vitro myelopoiesis by LGL: different effects on early and late progenitor cells.
    Matera L; Santoli D; Garbarino G; Pegoraro L; Bellone G; Pagliardi G
    J Immunol; 1986 Feb; 136(4):1260-5. PubMed ID: 3944457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural killer cell-mediated antitumor reactivity of rhesus monkeys.
    Savary CA; Lotzová E; Gray KN; Jardine JH
    Nat Immun Cell Growth Regul; 1985; 4(6):328-39. PubMed ID: 3878943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and purification of NK cells with lysosomotropic vital stains: correlation of lysosome content with NK activity.
    Shau H; Dawson JR
    J Immunol; 1985 Jul; 135(1):137-40. PubMed ID: 2582030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of natural cytotoxicity in vitro in a spontaneous rat tumor model.
    Zöller M; Matzku S
    J Immunol; 1980 Apr; 124(4):1683-90. PubMed ID: 6965955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
    Shakhar G; Ben-Eliyahu S
    J Immunol; 1998 Apr; 160(7):3251-8. PubMed ID: 9531281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry.
    Reynolds CW; Sharrow SO; Ortaldo JR; Herberman RB
    J Immunol; 1981 Dec; 127(6):2204-8. PubMed ID: 6975311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
    Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
    J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large granular lymphocytes are central cells in the interleukin-2-dependent differentiation pathway of natural killer cells.
    Lange A; Ernst M; Jaźwiec B; Ennen J; Flad HD
    Nat Immun Cell Growth Regul; 1987; 6(5):237-49. PubMed ID: 3502170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro migration of human large granular lymphocytes.
    Bottazzi B; Introna M; Allavena P; Villa A; Mantovani A
    J Immunol; 1985 Apr; 134(4):2316-21. PubMed ID: 2579138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-2-induced decrease in the buoyant density of cytotoxic cells and its relationship with proliferation.
    Sarin A; Saxena RK
    Nat Immun Cell Growth Regul; 1989; 8(5):279-89. PubMed ID: 2556638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enrichment of mouse splenic natural killer cells using discontinuous polyvinylpyrrolidone silica (Percoll) gradients.
    Patel MR; Linna TJ
    Immunology; 1984 Dec; 53(4):721-9. PubMed ID: 6094339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The proliferation and life-span of rat large granular lymphocytes: effects of cytokines.
    Vaage JT; Reynolds CW; Reynolds D; Fossum S; Rolstad B
    Eur J Immunol; 1989 Oct; 19(10):1895-902. PubMed ID: 2583227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large granular lymphocytes or "pit cells" from rat liver: isolation, ultrastructural characterization and natural killer activity.
    Bouwens L; Remels L; Baekeland M; Van Bossuyt H; Wisse E
    Eur J Immunol; 1987 Jan; 17(1):37-42. PubMed ID: 3816934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.